Improved survival of patients with prostate and breast cancer has come at a cost. Clinicians need to be vigilant with preventive care for patients with these cancers to maintain their dental and bone health.
More than a quarter of postmenopausal women and men ≥50 years of age were found to have osteoporosis a decade after undergoing Roux-en-Y gastric bypass surgery.
High social stress was associated with decreased bone mineral density over 6 years of follow-up.
Researchers used real-world data to compare changes in BMD after switching to teriparatide vs denosumab in patients with prior long-term bisphosphonate treatment.
A major osteoporotic fracture was recorded in 37.5% of participants, with incidence rates of 43%, 29.2%, and 33.1% in the RA, SLE, and primary Sjögren syndrome groups, respectively.
Researchers explored the association between frailty and the risk for osteoporotic fractures in patients with rheumatoid arthritis.
Bone turnover markers and Trabecular Bone Score might be useful tools to identify transmenopausal women who are at greater risk for bone loss.
Late-life women with osteoporosis, including those with comorbidities, may still be drug treatment candidates to prevent future hip fracture.
Researchers found no association between the use of DPP-4 inhibitors, GLP-1 receptor agonists, or SGLT2 inhibitors and the risk for fracture in patients with type 2 diabetes.
Exceeding recommended doses of vitamins B6 and B12 may cause adverse effects such as hip fracture in postmenopausal women.
